Suppr超能文献

天然来源的抗乙型肝炎病毒药物及其作用机制。

Naturally derived anti-hepatitis B virus agents and their mechanism of action.

作者信息

Wu Yi-Hang

机构信息

Yi-Hang Wu, Zhejiang Provincial Key Laboratory of Biometrology and Inspection and Quarantine, Department of Pharmacy, College of Life Sciences, China Jiliang University, Hangzhou 310018, Zhejiang Province, China.

出版信息

World J Gastroenterol. 2016 Jan 7;22(1):188-204. doi: 10.3748/wjg.v22.i1.188.

Abstract

Despite that some approved drugs and genetically engineered vaccines against hepatitis B virus (HBV) are available for HBV patients, HBV infection is still a severe public health problem in the world. All the approved therapeutic drugs (including interferon-alpha and nucleoside analogues) have their limitations. No drugs or therapeutic methods can cure hepatitis B so far. Therefore, it is urgently needed to discover and develop new anti-HBV drugs, especially non-nucleoside agents. Naturally originated compounds with enormous molecular complexity and diversity offer a great opportunity to find novel anti-HBV lead compounds with specific antiviral mechanisms. In this review, the natural products against HBV are discussed according to their chemical classes such as terpenes, lignans, phenolic acids, polyphenols, lactones, alkaloids and flavonoids. Furthermore, novel mode of action or new targets of some representative anti-HBV natural products are also discussed. The aim of this review is to report new discoveries and updates pertaining to anti-HBV natural products in the last 20 years, especially novel skeletons and mode of action. Although many natural products with various skeletons have been reported to exhibit potent anti-HBV effects to date, scarcely any of them are found in the list of conventional anti-HBV drugs worldwide. Additionly, in anti-HBV mechanism of action, only a few references reported new targets or novel mode of action of anti-HBV natural products.

摘要

尽管目前已有一些获批用于治疗乙型肝炎病毒(HBV)感染患者的药物和基因工程疫苗,但HBV感染仍是全球严重的公共卫生问题。所有已获批的治疗药物(包括α干扰素和核苷类似物)都有其局限性。目前尚无药物或治疗方法能够治愈乙型肝炎。因此,迫切需要发现和开发新型抗HBV药物,特别是非核苷类药物。具有巨大分子复杂性和多样性的天然来源化合物为寻找具有特定抗病毒机制的新型抗HBV先导化合物提供了绝佳机会。在这篇综述中,针对HBV的天然产物将根据其化学类别进行讨论,如萜类、木脂素、酚酸、多酚、内酯、生物碱和黄酮类。此外,还将讨论一些代表性抗HBV天然产物的新作用模式或新靶点。本综述的目的是报告过去20年中有关抗HBV天然产物的新发现和新进展,特别是新型骨架和作用模式。尽管迄今为止已报道许多具有各种骨架的天然产物具有强效抗HBV作用,但在全球传统抗HBV药物清单中几乎找不到它们。此外,在抗HBV作用机制方面,仅有少数参考文献报道了抗HBV天然产物的新靶点或新作用模式。

相似文献

1
Naturally derived anti-hepatitis B virus agents and their mechanism of action.
World J Gastroenterol. 2016 Jan 7;22(1):188-204. doi: 10.3748/wjg.v22.i1.188.
2
Natural Products: Review for Their Effects of Anti-HBV.
Biomed Res Int. 2020 Dec 9;2020:3972390. doi: 10.1155/2020/3972390. eCollection 2020.
4
A review of non-nucleoside anti-hepatitis B virus agents.
Eur J Med Chem. 2014 Mar 21;75:267-81. doi: 10.1016/j.ejmech.2014.01.046. Epub 2014 Jan 30.
5
Naturally occurring and synthetic bioactive molecules as novel non-nucleoside HBV inhibitors.
Mini Rev Med Chem. 2010 Feb;10(2):162-71. doi: 10.2174/138955710791185118.
6
Synthesis and biological evaluation of helioxanthin analogues.
Bioorg Med Chem. 2013 Apr 1;21(7):2163-76. doi: 10.1016/j.bmc.2012.11.037. Epub 2012 Dec 5.
7
Small-molecule inhibitors for the treatment of hepatitis B virus documented in patents.
Mini Rev Med Chem. 2013 Apr 1;13(5):749-76. doi: 10.2174/1389557511313050012.
8
Recent advance of the hepatitis B virus inhibitors: a medicinal chemistry overview.
Future Med Chem. 2015;7(5):587-607. doi: 10.4155/fmc.15.19.
9
Two new lignans and anti-HBV constituents from Illicium henryi.
Chem Biodivers. 2011 Apr;8(4):692-8. doi: 10.1002/cbdv.201000110.
10
Synthesis and the biological evaluation of arylnaphthalene lignans as anti-hepatitis B virus agents.
Bioorg Med Chem. 2010 Feb;18(3):1213-26. doi: 10.1016/j.bmc.2009.12.038. Epub 2009 Dec 21.

引用本文的文献

1
The Culprit Behind HBV-Infected Hepatocytes: NTCP.
Drug Des Devel Ther. 2024 Oct 28;18:4839-4858. doi: 10.2147/DDDT.S480151. eCollection 2024.
3
A Reappraisal of the Antiviral Properties of and Immune Regulation through Dietary Phytochemicals.
ACS Pharmacol Transl Sci. 2023 Oct 10;6(11):1600-1615. doi: 10.1021/acsptsci.3c00178. eCollection 2023 Nov 10.
5
Potential antiviral activities of chrysin against hepatitis B virus.
Gut Pathog. 2023 Mar 9;15(1):11. doi: 10.1186/s13099-023-00531-6.
6
Selected ginsenosides interfere efficiently with hepatitis B virus mRNA expression levels and suppress viral surface antigen secretion.
Heliyon. 2022 Aug 30;8(9):e10465. doi: 10.1016/j.heliyon.2022.e10465. eCollection 2022 Sep.
7
Secondary plant metabolites as potent drug candidates against antimicrobial-resistant pathogens.
SN Appl Sci. 2022;4(8):209. doi: 10.1007/s42452-022-05084-y. Epub 2022 Jul 8.
9
Alisol B 23-Acetate Increases the Antitumor Effect of Bufalin on Liver Cancer through Inactivating Wnt/-Catenin Axis.
Comput Math Methods Med. 2022 May 6;2022:6249534. doi: 10.1155/2022/6249534. eCollection 2022.

本文引用的文献

1
Strategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs.
J Hepatol. 2015 Apr;62(1 Suppl):S76-86. doi: 10.1016/j.jhep.2015.01.018.
2
Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors.
Bioorg Med Chem Lett. 2015 Apr 1;25(7):1568-71. doi: 10.1016/j.bmcl.2015.02.009. Epub 2015 Feb 16.
3
Isolation, synthesis and anti-hepatitis B virus evaluation of p-hydroxyacetophenone derivatives from Artemisia capillaris.
Bioorg Med Chem Lett. 2015 Apr 1;25(7):1509-14. doi: 10.1016/j.bmcl.2015.02.024. Epub 2015 Feb 18.
4
Chemical constituents of Swertia mussotii and their anti-hepatitis B virus activity.
Fitoterapia. 2015 Apr;102:15-22. doi: 10.1016/j.fitote.2015.01.020. Epub 2015 Feb 7.
5
Two new coumarin glycosides from Herpetospermum caudigerum.
J Asian Nat Prod Res. 2015;17(7):738-43. doi: 10.1080/10286020.2014.996137. Epub 2015 Jan 3.
6
Anti-hepatitis B virus active constituents from Swertia chirayita.
Fitoterapia. 2015 Jan;100:27-34. doi: 10.1016/j.fitote.2014.11.011. Epub 2014 Nov 21.
8
(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Antiviral Res. 2014 Nov;111:100-11. doi: 10.1016/j.antiviral.2014.09.009. Epub 2014 Sep 27.
9
In vitro and in vivo anti-hepatitis B virus activities of the lignan nirtetralin B isolated from Phyllanthus niruri L.
J Ethnopharmacol. 2014 Nov 18;157:62-8. doi: 10.1016/j.jep.2014.09.019. Epub 2014 Sep 27.
10
Antiviral herbs--present and future.
Infect Disord Drug Targets. 2014;14(1):61-73. doi: 10.2174/1871526514666140827102154.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验